Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
QJM : Monthly Journal of the Association of Physicians|August 22, 2012
Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism RegistryD Spirk, T Willenberg, D Aujesky, et al.International Journal of Cancer|August 19, 1992
Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic ratsA Pèlegrin, A Terskikh, D Hayoz, et al.Thrombosis and Haemostasis|April 9, 2011
Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) IID Spirk, J Ugi, W Korte, et al.Hypertension (Dallas, Tex. : 1979)|October 1, 1991
Evaluation of arterial compliance-pressure curves. Effect of antihypertensive drugsF Perret, V Mooser, D Hayoz, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 18, 2004
Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?J Delaloye, G Merlani, C Petignat, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumorsC Sessa, C Cuvier, S Caldiera, et al.The Journal of Surgical Research|August 18, 2004
Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous veinJ Rey, H Probst, L Mazzolai, et al.Human Genetics|December 22, 1999
SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patientsL Yin, V Ferrand, M F Lavoué, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinomaS Faivre, T Le Chevalier, C Monnerat, et al.Journal of Internal Medicine|March 25, 2005
Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvementP Chopard, J Dörffler-Melly, U Hess, et al.Pageof 13